Drug recall · October 30, 2024
EPINEPHrine 0.9% Sodium Chloride Injection USP recall
Why: cGMP violations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
EPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-060-58
- Lots / codes
Lot # C274-000038958, exp. date 17-Oct-24 C274-000039206, exp. date 23-Oct-24
- Quantity
- 753 bags
- Company
- Fresenius Kabi Compounding, LLC, Canton, MA
- Distribution
- Product was distributed to 125 direct accounts nationwide.
- Initiated
- September 25, 2024 · Voluntary: Firm initiated
- Classified
- October 21, 2024
- Reported
- October 30, 2024
- Ended
- August 15, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.